重视药物性肝损伤的临床研究*

doi:10.3969/j.issn.1672-5069.2014.06.001

实用肝脏病杂志 ›› 2014, Vol. 17 ›› Issue (6): 561-564.doi: 10.3969/j.issn.1672-5069.2014.06.001

• 述评 • 下一篇

重视药物性肝损伤的临床研究^*

茅益民

200001 上海市上海交通大学医学院附属仁济医院上海市消化疾病研究所/消化内科

收稿日期:2014-08-22 出版日期:2014-12-31 发布日期:2016-04-11
作者简介:茅益民,男,主任医师,教授,仁济医院国家药物临床研究中心副主任,上海市脂肪性肝病诊治研究中心副主任,国家科技部“十一五”和“十二五”重大专项课题评审首席专家。
基金资助:
国家“十二五”科技重大专项（2012ZX09303-001/2012ZX09401004）

Drug-induced liver injury:diagnosis,management and the challenge

Mao Yimin

Received:2014-08-22 Online:2014-12-31 Published:2016-04-11

摘要/Abstract

关键词: 药物性肝损伤, 临床研究, 发病机制

Key words: Drug-induced liver injury, Clinical study, Pathogenesis

茅益民. 重视药物性肝损伤的临床研究^*[J]. 实用肝脏病杂志, 2014, 17(6): 561-564.

Mao Yimin. Drug-induced liver injury:diagnosis,management and the challenge[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2014, 17(6): 561-564.

[1] Kaplowitz N. Idiosyncratic drug hepatotoxicity. Nat Rev Drug Discov,2005,4:489-499.
[2] Russmann S,Jetter A,Kullak-Ublick GA. Pharmacogenetics of drug-induced liver injury. Hepatology,2010,52（2）:748-761.
[3] van Swelm RP1,Laarakkers CM,van der Kuur EC,et al. Identification of novel translational urinary biomarkers for acetaminophen-induced acute liver injury using proteomic profiling in mice. PLoS One,2012,7（11）:e49524.
[4] Imaeda AB,Watanabe A,Sohail MA,et al. Acetaminopheninduced hepatotoxicity in mice is dependent on Tlr9 and the Nalp3inflammasome. J Clin Invest,2009,119:305-314.
[5] Jones DP,Lemasters JJ,Han D,et al. Mechanisms of pathogenesis in drug hepatotoxicity putting the stress on mitochondria. Mol Interv,2010,10（2）:98-111.
[6] Starkey Lewis PJ,Dear J,Platt Vet, et al. Circulating microRNAs as potential markers of human drug-induced liver injury. Hepatology,2011,54（5）,1767-1776.
[7] Starckx S,Batheja A,Verheyen GR,et al. Evaluation of miR-122 and other biomarkers in distinct acute liver injury in rats. Toxicol Pathol,2012,doi:10.1177/0192623312464436.
[8] Daly AK,Day CP. Genetic factors in the pathogenesis of drug-induced liver injury. In:Kaplowitz N,Deleve LD. Drug-induced liver disease,3rd ed. San Diego: Academic Press,2013:215-225.
[9] Lucena M,Molokhia M,Shen Y,et al. Susceptibility to amoxicillin-clavulanateinduced liver injury is influenced by multiple HLA class I and II alleles. Gastroenterology,2011,141:338-347.
[10] Daly AK,Donaldson PT,Bhatnagar P,et al. HLA-B*5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin. Nat Genet,2009,41（7）:816-819.
[11] 茅益民. 药物性肝损伤的临床诊断思路和评估.中华肝脏病杂志,2012,20（3）：167-169.
[12] Chalasani NP,Hayashi PH,Bonkovsky HL,et al. ACG Clinical Guideline:the diagnosis and management of idiosyncratic drug-induced liver injury. Am J Gastroenterol,2014,109（7）: 950-966.
[13] Rochon J,Protiva P,Seeff LB,et al. Reliability of the RUCAM for assessing causality in drug-induced liver injury. Hepatology,2008,48:1175-1183.
[14] Lewis JH. Causality assessment:Which is best—Expert opinion or RUCAM. Clin Liver Dis,2014,4（1）:4-8.
[15] Hoofnagle JH,Serrano J,Knoben JE,et al. LiverTox:a website on drug-induced liver injury. Hepatology,2013,57（3）:873-874.

重视药物性肝损伤的临床研究^*

Drug-induced liver injury:diagnosis,management and the challenge

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	潘美民, 李文娟, 蒋芳清, 杨丽晖, 谭永卫, 何娟, 阮建文, 蔡春琳. 慢性丙型肝炎患者血清IL-17A、FGF和IL-7水平与丙型肝炎病毒感染自发清除临床意义探讨^*[J]. 实用肝脏病杂志, 2019, 22(6): 840-843.
[2]	张瑞, 王剑, 陈世耀. 肝硬化门脉高压症并发血栓形成机制和治疗研究进展^*[J]. 实用肝脏病杂志, 2019, 22(6): 930-933.
[3]	梁巨波, 苗琪, 马雄. 胆管细胞型胆汁淤积诊治进展[J]. 实用肝脏病杂志, 2019, 22(6): 941-943.
[4]	吴欣, 郭杨志, 杜霄壤, 吴孟晋, 朱云, 冯兴中. 75例中药诱导的肝损伤患者临床特征分析*[J]. 实用肝脏病杂志, 2019, 22(5): 668-671.
[5]	朱光曦（综述）, 文良志, 陈东风（审校）. 非酒精性脂肪性肝病相关肝细胞癌发病机制研究进展[J]. 实用肝脏病杂志, 2019, 22(3): 453-456.
[6]	刘立伟,赵新颜. 药物性肝损伤临床与组织病理学特点[J]. 实用肝脏病杂志, 2019, 22(2): 160-163.
[7]	黄春洋,单晶,廖慧钰,黄云丽,韩莹,张小丹,杜晓菲,任美欣,边新渠,刘燕敏. 甲基强的松龙治疗药物性肝损伤患者临床及实验室特点分析^*[J]. 实用肝脏病杂志, 2019, 22(2): 208-211.
[8]	吴秀欣,张惠勇,张凯. 抗结核药物所致肝损伤患者血浆MiRNA-4284水平及其临床意义探讨^*[J]. 实用肝脏病杂志, 2019, 22(2): 212-215.
[9]	宋芳娇,朱冰,吕飒,田华,王海波,辛绍杰,游绍莉. 314例药物性肝衰竭患者临床特征分析^*[J]. 实用肝脏病杂志, 2019, 22(2): 216-219.
[10]	胡虎兰综述, 朱梦飞, 施军平审校. 慢性乙型肝炎合并非酒精性脂肪性肝病临床研究进展^*[J]. 实用肝脏病杂志, 2019, 22(1): 149-152.
[11]	孙文静, 陈东风. UCAM和Maria诊断标准用于评估1352例中国人药物性肝损伤文献分析[J]. 实用肝脏病杂志, 2018, 21(6): 881-884.
[12]	夏庚综述, 祁飞, 杨晋辉审校. 自身免疫性肝炎诱发因素研究进展[J]. 实用肝脏病杂志, 2018, 21(6): 983-986.
[13]	崔瑞冰, 阎明. 腹水原因解析[J]. 实用肝脏病杂志, 2018, 21(5): 657-660.
[14]	李越, 丁惠国. 乳糜性腹水诊治现状^*[J]. 实用肝脏病杂志, 2018, 21(5): 665-668.
[15]	佟欣, 樊华. 双环醇治疗胃癌化疗所致肝损伤患者肝功能指标的变化[J]. 实用肝脏病杂志, 2018, 21(4): 625-626.